Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal Cancer.
Pradeep S VirdeeJoanna MoschandreasVal GebskiSharon B LoveE Anne FrancisHarpreet S WasanGuy van HazelPeter GibbsRicky A SharmaPublished in: JMIR research protocols (2017)
FOXFIRE ISRCTN Registry ISRCTN83867919; http://www.isrctn.com/ISRCTN83867919 (Archived by WebCite at http://www.webcitation.org/6oN7axrvA). SIRFLOX ClinicalTrials.gov NCT00724503; https://clinicaltrials.gov/ ct2/show/NCT00724503 (Archived by WebCite at http://www.webcitation.org/6oN7lEGbD). FOXFIRE-Global ClinicalTrials.gov NCT01721954; https://clinicaltrials.gov/ct2/show/NCT01721954 (Archived by WebCite at http://www.webcitation.org/ 6oN7vvQvG).
Keyphrases
- phase iii
- open label
- metastatic colorectal cancer
- double blind
- radiation therapy
- clinical trial
- placebo controlled
- image quality
- phase ii
- dual energy
- computed tomography
- contrast enhanced
- locally advanced
- randomized controlled trial
- positron emission tomography
- magnetic resonance imaging
- study protocol
- magnetic resonance
- rectal cancer